Company News

Amyris Scales Up CBG Production

Leverages its industrial fermentation process capability.

Amyris Inc., a synthetic biotechnology company and supplier of sustainable and natural ingredients, has scaled up the commercial production of Cannabigerol (CBG) leveraging its industrial fermentation process capability.   Amyris expects to deliver about one ton of high purity CBG through fermentation as an alternative to the traditional production method of extraction from the Cannabis sativa L. plant. First commercial revenue from the sale of this molecule is anticipated this year as an ingred...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters